案例报告:对反感性寡核酸伏兰索森的过敏性脱敏
Rafael H Isaac1, Deyanira Gonzalez-Devia2,3, Carlos O Mendivil2,3
1Department of Internal Medicine, School of Medicine, Universidad de El Bosque, Bogotá, Colombia.
Frontiers in allergy
|June 26, 2023
概括
由于过敏反应,使用伏拉尼索森治疗家族胆小菌血症综合征 (FCS) 可能具有挑战性. 一个新的脱敏方案使得持续治疗成为可能,改善了患者的治疗结果.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 家庭性胆氏糖血症综合征 (FCS) 是一种罕见的遗传疾病,其特征是极高的甘油三水平.
- 对于FCS存在有限的治疗选择,沃兰索森是一种已批准的反感性寡核酸治疗方法.
- 伏拉尼索森的疗效值得注意,但由于副作用,包括过敏反应等,中止治疗是令人担忧的.
研究的目的:
- 描述一个患有FCS的患者对volanesorsen立即过敏反应的病例.
- 评估一项针对伏拉尼索森的新型脱敏方案在管理过敏反应中的有效性.
- 突出使FCS持续治疗成为可能的脱敏方案的重要性.
主要方法:
- 一名24岁的女性患者经过基因确认的FCS和复发性胰腺炎被治疗了volanesorsen.
- 患者在第五剂量后出现了疹,导致断药volanesorsen.
- 实施了脱敏方案,允许随后的管理没有过敏反应.
主要成果:
- 伏兰索森治疗最初将甘油三水平正常化至<200 mg/dl.
- 患者立即出现了对volanesorsen.sen的过敏反应 (尿疹).
- 脱敏方案成功地使得Volanesorsen治疗能够继续进行,而不会导致过敏反应的复发.
结论:
- 伏拉尼索森在管理FCS方面是有效的,但可以引起过敏反应.
- 一个脱敏方案可以是一个有效的策略,以克服火焰或引起的过敏.
- 成功的脱敏化有助于继续治疗,可能改善FCS患者的生活质量和生存率.
相关概念视频
Desensitization and Tachyphylaxis
1.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.9K
GPCR Desensitization
6.2K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
Hypersensitivities
799
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
799
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
208
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
208
Allergic Drug Reactions
898
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
898


